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The resident internal medicine called from the Emergency
Department (ED). “Can you please come and see my
patient, I think he is becoming septic and needs admission
to intensive care”. In the ED we found a confused older
patient with an oxygen mask who was clearly dyspnoeic,
the urinary catheter was ﬁlled with a dark brown ﬂuid, the
collecting bag was empty. The resident reported that he
admitted the patient 4 h earlier as he suspected pneumonia.
On admission the patient was hypoxic but this clearly
improved with the supplemental oxygen. The resident was
still waiting for all the laboratory results and the chest
X-ray. However, now that the patient had developed
hypotension he thought the patient was clearly at risk
and intensive care admission was required. When we
asked why he had not called us earlier, he replied that he
intended to admit the patient to the general ward as he was
haemodynamically stable and oxygenation had improved
on supplemental oxygen so intensive care admission
was not required. When reviewing the blood sample
that was drawn 30min following presentation, besides
hypoxaemia, an increased lactate level of 4.6mmol/l was
present. The resident pointed out that hyperlactataemia in
sepsis is not related to tissue hypoxiabut rather is a marker
of increased aerobic metabolism. Therefore he thought
there was no need to react to this hyperlactataemia. Where
did this resident go wrong?
Increased blood lactate levels in critically ill patients
are generally associated with increased morbidity and
mortality [1, 2]. Even haemodynamically stable patients
with raised lactate levels, a condition referred to as
compensated shock, are at increased risk of dying [3, 4].
This not only applies to patients admitted to the intensive
care unit; also early in the course of illness, increased
blood lactate levels are related to increased morbidity and
mortality. In a study published in this issue of Intensive
Care Medicine, Howell et al. [5] evaluated the prognostic
value of one single venous lactate measurement shortly
after admission to the ED in patients with clinically
suspected infection. Their study is a follow-up on a pre-
liminary report [6], where they did not take into account
possible confounding factors such as co-morbidities and
vital signs. In the current prospective observational cohort
study (n= 1,287), the authors constructed a multivariate
model, controlling for age, blood pressure, presence
of malignancy, platelet count and blood urea nitrogen
level. They showed that venous lactate predicted 28-
day in-hospital mortality. The predictive power of the
lactate level was independent of blood pressure and co-
variates. In patients with normal blood pressure, increased
blood lactate levels (>4.0mmol/l) were associated with
a ten times higher mortality rate than normal lactate
levels (mortality 26.5%). Others have reported simi-
lar results in other patient populations. Lavery et al. [7]
measured venous lactate within 10min following admis-
sion to the ED in 375 trauma patients. This study showed
that an increased lactate level (>2.0 mmol/l) was a better
predictor of morbidity and mortality than physiological
triage criteria (composed of heart rate, blood pressure,
Glasgow coma scale and respiratory rate). Rivers et al. [8]
also showedthat traditional physiologicalvariablesdid not
adequately determine septic patients at risk of increased1864
mortality. However, when Hucker et al. [9] included all
patients admitted to the hospital following presentation at
the ED, neither clinical measures nor venous lactate could
adequately predict hospital mortality or length of hospital
stay. The short-term evolution in blood lactate has also
been associated with mortality. In intensive care patients
with circulatory shock, Vincent et al. [10] showed that
20min following ﬂuid resuscitation, non-survivors could
already be distinguished from the surviving patients. In
the ED, Nguyen et al. [11] observed the evolution of serial
lactate levels in patients with severe sepsis during the ﬁrst
6h of treatment. In this study, a 10% decrease in lactate
levels during the 6-h study period was related to an 11%
decrease in the likelihood of mortality. Furthermore, 29%
of the patients that did not show a decreasein lactate levels
during the study did not have hypotension, where the mor-
tality in this group still exceeded 55% [11]. As venous [7,
12] and capillary [13] blood can be used to reﬂect arterial
blood lactate levels with a turnaround time of less than
2min [13], the clinician can rapidly identify a group of
patients that, irrespective of their haemodynamic stability,
has an increased risk of morbidity and mortality. This
thus represents a faster and more reliable (independent of
inter- and intra-observer variations) severity scoring than
commonly used triage and scoring systems.
Two important questions remain, not so much to
assess the use of lactate levels as a risk assessment tool,
but more to decide what therapeutic measures should
be taken when lactate levels are increased. First, why
do patients with more often die than patients without
increased lactate levels? A systemic imbalance between
oxygen delivery (DO2) and demand causes lactate levels
to sharply rise, both in various experimental [14] and in
clinical [15] conditions. Increased lactate levels have thus
long been used to reﬂect the presence of tissue hypoxia.
Hypoxia results in cell death and thus, if not resolved,
leads to organ failure. Increased lactate levels and the
duration of hyperlactataemia have indeed been associated
with the level of organ failure in patients with septic
shock [16]. However, besides this anaerobic mechanism,
aerobic processes are also known to raise lactate levels in
critically ill patients. First, increased aerobic glycolysis by
cytokine-mediated cellular uptake of glucose [17] or by
catecholamine-stimulated Na-K pump hyperactivity [18]
can result in increased pyruvate production that exceeds
the capacity of the pyruvate dehydrogenase enzyme
complex (PDH) and thus results in increased lactate
levels by mass effect. Second, in sepsis, PDH dysfunc-
tion has been reported [19]. Third, the lung is known to
produce lactate, probably marking metabolic adaptations
in response to inﬂammatory mediators rather than tissue
hypoxia [20, 21]. Finally, reduced clearance of lactate will
result in increased levels even when lactate production
is not increased. In hemodynamically stable patients
with sepsis, impaired clearance has been associated with
increased lactate levels [22]. Second, what therapeutic
actions should be taken in patients with increased blood
lactate levels to improve their prognosis? From earlier
studies in the 1980s and 1990s it is clear that correcting
lactate levels itself will not improve outcome of critically
ill patients [23, 24]. As oxygen supply dependency, as
a marker of tissue hypoxia and increased lactate levels, is
present in the early phase of critical illness [25], it seems
logical to improve tissue oxygen delivery in patients
with increased lactate levels. Several studies aimed at
improving tissue oxygenation in patients with increased
lactate levels have beenassociated with an improvementin
morbidity and mortality [3, 8, 26, 27]. Furthermore, high
lactate levels may reﬂect microcirculatory derangement,
hampering oxygen utilization at the tissue level [28].
This is illustrated by the observation that improving
capillary perfusion has been shown to decrease lactate
levels independent of changes in systemic haemodynamic
variables [29]. However, randomized controlled trials in
critically ill patients to provethis have notbeen performed.
A recently started randomized controlled multi-centre
trial, that is now halfway, is designed to evaluate the
value of lactate level-guided therapy early in the course
of critical illness (http://www.clinicaltrials.gov/ct/show/
NCT00270673?order=1).
However, increased lactate levels, as a marker of tis-
sue hypoxia in critically ill patients, remain a matter of
debate [30]. Given the many processes that may affect the
ultimate concentration of lactate, both individual lactate
levelsandthe changein levelovertime maywellreﬂectthe
general homeostasis of the critically ill patient. The cur-
rent study by Howell et al. [5] clearly shows that the use of
a single measurement of venous lactate, that can be avail-
able rapidly following admission to the ED, provides the
clinician with better risk assessment, possibly with a clear
direction to diagnosis and therapy, than vital signs. In the
case presentation the resident could thus have diagnosed
a severe disturbance in the homeostasis of his patient, de-
spite the haemodynamic stability for the next few hours,
30min following admission when the ﬁrst lactate level be-
came available. The intensivist could then perhaps have
made a bigger impact on the outcome of this patient, who
died several days following admission.1865
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